trial · primary record
trastuzumab derxutecan
Breast Cancer Metastatic
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 80 |
| Primary completion | 2029-08-01 |
| Primary endpoint | Progression Free Survival (PFS) |
| Registry ID | NCT06680596 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:32:08.056Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06680596
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.